Preclinical characterization of allogeneic CAR ?d T Cell therapy for prostate cancer targeting a novel dimeric epitope on PSMA

被引：0
|
作者：
Ramadoss, Nitya S.
Speltz, Elizabeth
Capillo, Tonya
Meaddough, Erika
Wang, Katherine
Friedland, Natalia
Wong, Jonathan
Teague, Alexander G.
Azameera, Aruna
Gundurao, Smitha Rao Yelaguli
Kaur, Ramandeep
Smith-Boeck, Morgan
Salum, Michael
Chanthery, Yvan
Green, Shon
Herrman, Marissa
Nishimoto, Kevin P.
Aftab, Blake T.
Bhat, Arun
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-C117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C117
引用
收藏
页数：2
相关论文
共 50 条
  • [41] COMBINING INNATE IMMUNE TARGETING WITH ADAPTIVE IMMUNE POWER: EXPLOITING NKG2D FOR AUTOLOGOUS AND ALLOGENEIC CAR T CELL THERAPY
    Gilham, D.
    HUMAN GENE THERAPY, 2019, 30 (12) : A2 - A2
  • [42] Preclinical Efficacy of a Novel CD8-Targeted Fusosome for In Vivo CAR T Cell Therapy
    Chaturvedi, Vandana
    Green, Jesse
    Zipp, Garrett
    Lampano, Aaron
    Liang, Ouwen
    O'Rourke, Allison
    Granger, Brian
    Elpek, Kutlu G.
    van Hoeven, Neal
    Fry, Terry
    BLOOD, 2023, 142
  • [43] Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer
    Eder, Matthias
    Schaefer, Martin
    Bauder-Wuest, Ulrike
    Haberkorn, Uwe
    Eisenhut, Michael
    Kopka, Klaus
    PROSTATE, 2014, 74 (06): : 659 - 668
  • [44] Development of Novel CAR-T Cell Therapy Targeting Disialoganglioside (GD2)
    Negishi, Kohei
    Akahori, Yasushi
    Seo, Naohiro
    Fujiwara, Hiroshi
    CANCER SCIENCE, 2024, 115 : 1882 - 1882
  • [45] Development of Novel CAR-T Cell Therapy Targeting Disialoganglioside (GD2)
    Negishi, Kohei
    Akahori, Yasushi
    Seo, Naohiro
    Wang, Linan
    Shiku, Hiroshi
    Fujiwara, Hiroshi
    CANCER SCIENCE, 2023, 114 : 1417 - 1417
  • [46] Preclinical Characterization of a Novel Diphenyl Benzamide Selective ERα Agonist for Hormone Therapy in Prostate Cancer
    Coss, Christopher C.
    Jones, Amanda
    Parke, Deanna N.
    Narayanan, Ramesh
    Barrett, Christina M.
    Kearbey, Jeffrey D.
    Veverka, Karen A.
    Miller, Duane D.
    Morton, Ronald A.
    Steiner, Mitchell S.
    Dalton, James T.
    ENDOCRINOLOGY, 2012, 153 (03) : 1070 - 1081
  • [47] A Novel Chimeric Antigen Receptor T Cell (CAR T) Therapy Target for Breast Cancer
    Williams, A. D.
    Posey, A.
    Tchou, J.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S52 - S52
  • [48] Preclinical Evaluation of 225Ac-rhPSMA-10.1, a Novel Radiohybrid PSMA Compound for Targeted Alpha Therapy of Prostate Cancer
    Vassileva, V.
    Waldron, B.
    Wurzer, A.
    D'Alessandria, C.
    Gronlund, R. Veggerby
    Hallund, M. Wikke
    Gauden, D.
    Stevens, D.
    Foxton, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S65 - S66
  • [49] Development of CAR T-cell therapy targeting glypican-3 in liver cancer
    Li, Dan
    Li, Nan
    Zhang, Yifan
    Fu, Haiying
    Torres, Madeline B.
    Wang, Qun
    Greten, Tim F.
    Ho, Mitchell
    CANCER RESEARCH, 2018, 78 (13)
  • [50] Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
    Seitz, Christian M.
    Mittelstaet, Joerg
    Atar, Daniel
    Hau, Jana
    Reiter, Selina
    Illi, Clara
    Kieble, Verena
    Engert, Fabian
    Drees, Britta
    Bender, Giulia
    Krahl, Ann-Christin
    Knopf, Philipp
    Schroeder, Sarah
    Paulsen, Nikolas
    Rokhvarguer, Alexander
    Scheuermann, Sophia
    Rapp, Elena
    Mast, Anna-Sophia
    Rabsteyn, Armin
    Schleicher, Sabine
    Grote, Stefan
    Schilbach, Karin
    Kneilling, Manfred
    Pichler, Bernd
    Lock, Dominik
    Kotter, Bettina
    Dapa, Sandra
    Miltenyi, Stefan
    Kaiser, Andrew
    Lang, Peter
    Handgretinger, Rupert
    Schlegel, Patrick
    ONCOIMMUNOLOGY, 2021, 10 (01):
12345